Document is current
Any future updates will be listed below
-
Authors
Maurer, Mathew S. https://orcid.org/0000-0001-5400-5008
Soman, Prem https://orcid.org/0000-0003-1425-6536
Hernandez, Adrian https://orcid.org/0000-0003-3387-9616
Garcia-Pavia, Pablo https://orcid.org/0000-0002-5470-2257
Signorovitch, James https://orcid.org/0000-0002-4067-8962
Wei, L. J. https://orcid.org/0000-0002-8582-920X
Hanna, Mazen https://orcid.org/0000-0002-7251-3003
Ruberg, Frederick L. https://orcid.org/0000-0002-6424-4413
Kittleson, Michelle https://orcid.org/0000-0003-4492-2691
Kazi, Dhruv https://orcid.org/0000-0002-9510-2979
Dorbala, Sharmila https://orcid.org/0000-0003-1462-1185
Hsu, Kristen https://orcid.org/0000-0003-2106-3652
Lousada, Isabelle https://orcid.org/0000-0002-3506-0359
Adigun, Rosalyn https://orcid.org/0000-0002-5716-9443
Dunnmon, Preston https://orcid.org/0009-0002-8564-6187
Kelly, Jeffery https://orcid.org/0000-0001-8943-3395
Gillmore, Julian https://orcid.org/0000-0001-6174-9232
,
Masri, Ahmad
Morris, Alanna
Dispenzieri, Angela
Berk, John
Ferdinand, Keith
Shah, Keyur
McCausland, Kristen
Henshaw, Lynnette
Grogan, Martha
Azzarone, Megan
Polydefkis, Michael
Fiuzat, Mona
Bullock-Palmer, Renee P.
Booth, Benjamin
Gandotra, Charu
Mittmann, Clemens
Welsh, Cynthia
Dawoud, Dalia
Zouridakis, Emmanouil
Cunningham, Francesca
Race, Jean-Michel
Li, Jie
Sakushima, Ken
Jawidzik, Laura
Campbell, Michelle
Rahman, Motiur
Stockbridge, Norman L.
Lloyd, Rhea
Bent, Robyn
Kuehn, Sylvia
Chambers, Wiley
Slugg, Andrew
Angeli, Franca
Fox, Johnathan
Cowie, Martin
Meldorf, Matt
Maitland, Michael
Roberts, Michael
Mercuri, Michele
Tsimikas, Sam
Sanjurjo, Victoria
-
Funding
Funding for this research was provided by:
National Institute of Aging (1R13AG082492-01)
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 29 April 2024
First Online: 4 June 2024
Declarations
:
: Mathew Maurer: Grant support from NIH R01HL139671 and R01AG081582-01; grants and personal fees from Alnylam, Pfizer, Eidos, Prothena, and Ionis; and personal fees from AstraZeneca, Akcea, Intellia, and Novo-Nordisk. Prem Soman: Grant support Pfizer; Personal fees from Alnylam and BridgeBio. Adrian Hernandez: Consultant/scientific advisor to Amgen, AstraZeneca, Bayer, Bioforumis, Bristol Myer Squibb, Boehringer Engelheim, Boston Scientific, Cytokinetics, Eidos/Bridgebio, GlaxoSmith Kline, Intercept Pharmaceuticals, Intellia Therapeutics, MyoKardia, Novartis, NovoNordisk, Pfizer and TikkunLev. Research support from American Heart Association, Aires Pharmaceuticals, Amgen, American Regent, AstraZeneca, Boehringer Engelheim, Bristol-Myers Squibb, Cytokinetics, Intellia Therapeutics, Genentech, GlaxoSmithKleine, Merck, National Heart, Lung, and Blood Institute (NHLBI), Novartis, Patient-Centered Outcomes Research Institute (PCORI), Pfizer and Verily. Pablo Garcia-Pavia: Speaking fees from Pfizer, BridgeBio, Ionis Pharmaceuticals, AstraZeneca, NovoNordisk, Intellia and Alnylam Pharmaceuticals, consulting fees from Pfizer, BridgeBio, Neuroimmune, Alnylam Pharmaceuticals, AstraZeneca, NovoNordisk, ATTRalus, Intellia, General Electric and Alexion, and research/educational support to his institution from Pfizer, BridgeBio and Alnylam Pharmaceuticals. James Signorovitch: Employee of Analysis Group Inc., which provides research and consulting services to biopharma and has received consulting fees from ARC. Mazen Hanna: Served on advisory boards for Pfizer, BridgeBio, Ionis Pharmaceuticals, and Alexion Pharmaceuticals. Frederick Ruberg: Research support: NIH/NHLBI (R01 HL139671), Pfizer, Akcea/Ionis, Alnylam Consulting: ATTRalus, AstraZeneca. Sharmila Dorbala: Grant support from NIH; grants from Pfizer, ATTRalus, Siemens, Phillips; Consulting fees from Pfizer, Novo-Nordisk, BridgeBio. Jeffery Kelly: Consultant/scientific advisor to ATTRalus, George E. Hewitt Foundation for Medical Research, NeoChromosome, Pfizer, Protego, Curebound, Yumanity. Board of Directors member for George E. Hewitt Foundation for Medical Research, Protego, Yumanity. Stock in NeoChromosome, Pfizer, Protego, Yumanity. Julian Gillmore: Consultancy fees from Alnylam, Pfizer, BridgeBio, Ionis, AstraZeneca, ATTRalus, Intellia, Lycia. L J Wei, Michelle Kittleson, Dhruv Kazi, Kristen Hsu, Isabelle Lousada, Rosalyn Adigun, Preston Dunnmon have nothing to disclose.
: The information contained in this article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Permission was received by the Amyloidosis Forum to publish this review article.
